USPTO 2015–2025 USPTO PatentsView US Corporation

Caris MPI, Inc.

USPTO PatentsView assignee record — 13 granted patents across 10 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G16B (BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY).

13
Total patents granted
10
CPC technology areas
22.3
Avg claims per patent
-56%
5-year filing velocity

Portfolio overview

Caris MPI, Inc. has been granted 13 US utility patents between 2015 and 2025, placing Caris MPI, Inc. at rank #20,933 across all assignees tracked by PlainPatent. This portfolio spans 10 distinct Cooperative Patent Classification (CPC) subclasses, averaging 22.3 claims per patent with primary concentration in G16B (BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY). As a US Corporation, Caris MPI, Inc. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 53.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 4 grants, compared with 9 in the 2015–2019 window — a -56% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Caris MPI, Inc.'s 22.3 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 10 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Caris MPI, Inc. against peers pursuing similar technology classes.

How does Caris compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Caris holds 13 patents — placing it at rank #20,933 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2015–2025

0123456 201520162022202320242025 1
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Caris MPI, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 4 30.8%
2016 5 38.5%
2022 1 7.7%
2023 1 7.7%
2024 1 7.7%
2025 1 7.7%

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Complex
Velocity Declining

Where it ranks

Overall rank by patents

#20,933

Across all tracked assignees

Innovation Score

53.7 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Caris MPI, Inc. hold?
Caris MPI, Inc. holds 13 US granted patents filed between 2015 and 2025, spanning 10 technology areas.
What is Caris MPI, Inc.'s Innovation Score?
Caris MPI, Inc. has an Innovation Score of 53.7 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Caris MPI, Inc. focus on?
Caris MPI, Inc.'s top technology area is G16B (BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY) with 13 patents. The company has filed patents in 10 CPC subclasses total.
Is Caris MPI, Inc.'s patent filing rate increasing or decreasing?
Caris MPI, Inc.'s recent filing velocity is -56% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Caris MPI, Inc.'s patents?
Caris MPI, Inc.'s patents average 22.3 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the Caris MPI, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope